Structural, Spectroscopic, and Docking Analysis of N,O‐Donor Ligand Metal Complex Nanoparticles With Hypolipidemic Effects via Lipoprotein Lipase Activation in High‐Fat Diet Mice
Open Access
- 27 December 2024
- journal article
- research article
- Published by Wiley in Chemistry & Biodiversity
- Vol. 22 (5) , e202403003
Abstract
New Cd(II), Zn(II), and Cu(II) chelates with cetirizine.2HCl (CETZ.2HCl) in incidence of 1,10 phenanthroline monohydrate (Phen.H 2 O) were synthesized in search of new biologically active compounds. The ligands and their chelates were described by 1H NMR, FT‐IR, elemental analysis, UV–vis spectrophotometry, thermal analyses, molar conductance, x‐ray diffraction (XRD), and magnetic‐susceptibility measurements. FT‐IR demonstrated that CETZ.2HCl is bonded with metal ions, as a monodentate via carboxylate oxygen atom and Phen.H 2 O chelated via two nitrogen atoms. The molar conductivity data showed that the complexes were nonelectrolytes, whereas XRD data supported that the compounds were crystalline. Density functional theory (DFT) was utilized to gain insight into the compounds' optimized design. The effects of CETZ.2HCl and the complexes on the activity of lipoprotein‐(L)‐lipase in mice were investigated. Unlike Cd(II) complex, all the other compounds exhibited significant increase in lipase activity, with reduction in triglycerides. Cu(II) and Zn(II) complexes showed robust hypolipidemic efficacy evidenced by lower levels of total cholesterol and low‐density lipoprotein (LDL), concomitant with higher levels of high‐density lipoprotein (HDL). Furthermore, Zn(II) complex was a safe alternative as it has a lower liver toxicity. Molecular docking demonstrated that Cu(II) and Zn(II) chelates exhibited greater affinities to lipase than the parent ligand. Finally, Cu(II) complex showed the highest antibacterial activity.Keywords
This publication has 90 references indexed in Scilit:
- RETRACTED: Synthesis, structural characterization, antioxidant, cytotoxic activities and docking studies of Schiff base Cu(II) complexesHeliyon, 2023
- Rhynchophylline relieves nonalcoholic fatty liver disease by activating lipase and increasing energy metabolismInternational Immunopharmacology, 2023
- Inhibition of hepatic apolipoprotein A-I gene expression by histamineEuropean Journal of Pharmacology, 2018
- Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseasesDrug Discovery Today, 2017
- Novel metal based anti-tuberculosis agent: Synthesis, characterization, catalytic and pharmacological activities of copper complexesEuropean Journal of Medicinal Chemistry, 2012
- Synthesis, spectral characterization and bio-analysis of some organotin(IV) complexesEuropean Journal of Medicinal Chemistry, 2008
- Selection, synthesis, and structure–activity relationship of tetrahydropyrido[4,3-d]pyrimidine-2,4-diones as human GnRH receptor antagonistsBioorganic & Medicinal Chemistry, 2007
- Organoiodine(III) mediated synthesis of 3,9-diaryl- and 3,9-difuryl-bis-1,2,4-triazolo[4,3-a][4,3-c]pyrimidines as antibacterial agentsEuropean Journal of Medicinal Chemistry, 2007
- 2-Cyanoaminopyrimidines as a class of antitumor agents that promote tubulin polymerizationBioorganic & Medicinal Chemistry Letters, 2007
- Cetirizine dihydrochloride interaction with some diclofenac complexesEuropean Journal of Pharmaceutical Sciences, 2005